Navigation Links
Genzyme Launches Cholestagel(R) in Europe
Date:10/23/2007

rolemia (FH) -- an inherited disorder that causes exceptionally high levels of LDL-cholesterol -- who cannot reach their target LDL- cholesterol levels with a maximum regimen of statins and ezetimibe alone.

This double-blind, randomized "TRIPLE" study will involve 80 patients with FH enrolled in six European centers (including in the UK, Netherlands, Sweden and France) and preliminary results are expected in Q3 2008.

"Patients with genetic conditions like familial hypercholesterolemia are at particularly high risk of early coronary heart disease," said Dr. Anthony Wierzbicki, from London's St. Thomas' Hospital and a board member and chairman of the Medical Scientific and Research Committee of FH patient association 'Heart UK'. "Patients have to take multiple cholesterol-lowering therapies and yet still often require further cholesterol reduction to reach target lipid levels recommended for patients at risk of cardiovascular events. New non-systemic agents are a welcome addition for these patients to help them achieve these targets."

Unlike most other cholesterol-lowering treatments, Cholestagel is non- systemic, and therefore is not absorbed into the bloodstream. Cholestagel binds bile acids in the intestine, impeding their reabsorption. This process -- called bile acid sequestration -- results in an increased clearance of LDL cholesterol from the blood. Cholestagel is also well tolerated, with minimal gastrointestinal side effects similar to those seen in placebo, and has limited drug-interaction.

Colesevelam has been approved for use in the United States since 2000, where it is marketed by Daiichi Sankyo Inc. under the trade name WelChol(R). Genzyme plans to launch Cholestagel in the United Kingdom, the Netherlands and the Scandinavian region this quarter, and in additional European countries next year. Genzyme also intends to pursue regulatory approvals for Cholestagel in Latin America, Canada, and the Asia Pacific region.

Genzyme ha
'/>"/>

SOURCE Genzyme Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Cytochroma settles lawsuit with Genzyme
2. Genzyme sues former Bone Care employees
3. Genzyme acquistion of Bone Care approved, significant impact forecast
4. Merge launches diagnostic mammography workstation in Europe
5. Einstein Wireless launches cellular alert system
6. Logistics Health launches compliance management tool
7. UW-Madison launches new high-speed research network
8. UWM launches research foundation
9. TeraMedica launches information manager
10. GE Healthcare launches hybrid electronic record
11. Cedara launches new version of DICOM toolkit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... RESEARCH TRIANGLE PARK, N.C. , April 21, ... ) announced today that it will release its first ... April 28, 2015. United Therapeutics will host ... 9:00 a.m. Eastern Time.  The teleconference is accessible by ... of the teleconference will be available for one week ...
(Date:4/21/2015)... 2015 YourEncore, an Indianapolis, Indiana-based ... consumer products and food sciences industries solve complex ... for Clinical Research Excellence and Safety (ACRES), a ... clinical research, have partnered to speed innovation in ... YourEncore brings to ACRES experts with proven experience, ...
(Date:4/20/2015)... FREMONT, Calif. , April 20, 2015 /PRNewswire/ ... biopharmaceutical company focused on cardio-renal, gastrointestinal and metabolic ... MBBS, MRCP, has joined the Company,s Board of ... management and board level experience, having built and ... clinical development, regulatory approval and into healthcare systems ...
(Date:4/20/2015)... 20, 2015 /CNW/ - Portage Biotech Inc. ("Portage" or ... is pleased to announce that its wholly owned subsidiary, ... study that showed one of its proprietary human-derived CPP ... tissue through inhibition of NFkB signalling even if administered ... permeability of the blood brain barrier (BBB) in mice ...
Breaking Biology Technology:YourEncore and ACRES Partner to Drive Innovation in Clinical Research 2YourEncore and ACRES Partner to Drive Innovation in Clinical Research 3Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 2Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 3Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 4Portage's CPP Platform Delivers a Peptide Cargo Across Blood Brain Barrier 2Portage's CPP Platform Delivers a Peptide Cargo Across Blood Brain Barrier 3
... deal from January through March this year, according to the ... state said that the lack of deals in a quarter ... another reminder that capital is hard to come by. , ... sometimes adding up to around $20 million or $25 million, ...
... a California life-science firm, announced on Monday afternoon that ... in Madison, over a patent issue. Third Wave sued ... technologies involved are some of Third Wave's Invader products ... said in a release that FullVelocity allows researchers to ...
... computer just isn't enough. Researchers at the University of ... groups of tightly networked computers that share tasks such ... Smith and David Schwartz are working with the ... tasks manageable. The system used is Condor, software developed ...
Cached Biology Technology:Money Tree survey shows lull in Wisconsin venture capital deals 2Money Tree survey shows lull in Wisconsin venture capital deals 3
(Date:3/26/2015)... TORONTO , March 26, 2015 ... premier family, social, recreation and athletic club, today announced ... designed to allow freedom of movement for members and ... "Following a comprehensive process, we selected FST,s IMID ... sophistication and convenience for our members and staff, in ...
(Date:3/24/2015)... March 24, 2015   Crossmatch ™, a ... announced that its U.are.U ® 4500 Fingerprint ... Goorin Bros . to achieve PCI compliance for ... access to the POS terminal, protecting the retailer ... data breaches. With one-third of ...
(Date:3/23/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... mobile commerce market, announces its biometric payment technology, the Wocket® ... television starting March 30 th . ... New York markets. ... about our new ad campaign following the recent initial shipment ...
Breaking Biology News(10 mins):Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3
... 2013The repair of ruptured tendons often requires the use of ... bone. A tissue-engineered collagen graft can reduce the complications associated ... be able to support full load bearing until integrated into ... this tissue-engineered tendon is described in BioResearch Open Access ...
... agent for Alzheimer,s disease, and its derivative, ... neuroprotective effect against Alzheimer,s disease-relevant insults. Al-though ... S14G-humanin exerts its effects remains unclear. A ... from Henan Provincial People,s Hospital, China investigated ...
... vegetation follows the change of the seasons. After a winter ... now brought a new correlation to light: The colder the ... warmer winters can be expected as the climate changes, the ... and later giving an advantage to shrubs and invasive ...
Cached Biology News:Novel technique for suturing tissue-engineered collagen graft improves tendon repair 2Warm winters let trees sleep longer 2
... The Fujifilm Life Science FLA-7000 excels at ... CBB-stained gel documentation. It features four easy-to-access ... and a filter for Imaging Plates) for ... a customizable choice of four kinds of ...
... Software has been optimized for the analysis ... the software to quickly and accurately locate ... of an ELISA plate or each section ... has been customized to incorporate standard ELISA ...
For microscopy...
... in the base hold 10 l of ... hydration around the edges of the coverslip. ... waterbath contamination. This chamber can be used ... ovens. Linkage: This CLS number is a ...
Biology Products: